181 related articles for article (PubMed ID: 30042917)
1. Topical Treatment of Eyebrow Hypotrichosis with Bimatoprost 0.03% Solution: Case Report and Literature Review.
Riahi RR; Cohen PR
Cureus; 2018 May; 10(5):e2666. PubMed ID: 30042917
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.
Chanasumon N; Sriphojanart T; Suchonwanit P
Drug Des Devel Ther; 2018; 12():365-372. PubMed ID: 29503529
[TBL] [Abstract][Full Text] [Related]
3. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
4. Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study.
Beer KR; Julius H; Dunn M; Wilson F
Dermatol Surg; 2013 Jul; 39(7):1079-87. PubMed ID: 23617229
[TBL] [Abstract][Full Text] [Related]
5. Eyebrow growth pattern analysis in patients with eyebrow hypotrichosis after receiving topical treatment: A retrospective study.
Suchonwanit P; Thammarucha S
J Cosmet Dermatol; 2020 Jun; 19(6):1404-1408. PubMed ID: 31541563
[TBL] [Abstract][Full Text] [Related]
6. Topical bimatoprost for the treatment of eyebrow hypotrichosis.
Schweiger ES; Pinchover L; Bernstein RM
J Drugs Dermatol; 2012 Jan; 11(1):106-8. PubMed ID: 22206085
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Vehicle-Controlled Study.
Suchonwanit P; Chanasumon N; Sriphojanart T
Dermatol Surg; 2019 Dec; 45(12):1549-1556. PubMed ID: 30913051
[TBL] [Abstract][Full Text] [Related]
8. Bimatoprost in the treatment of eyelash hypotrichosis.
Law SK
Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
[TBL] [Abstract][Full Text] [Related]
9. Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis.
Carruthers J; Beer K; Carruthers A; Coleman WP; Draelos ZD; Jones D; Goldman MP; Pucci ML; VanDenburgh A; Weng E; Whitcup SM
Dermatol Surg; 2016 May; 42(5):608-17. PubMed ID: 27124878
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial.
Zaky MS; Hashem OA; Mahfouz SM; Elsaie ML
Arch Dermatol Res; 2023 Nov; 315(9):2635-2641. PubMed ID: 37517060
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study.
Suchonwanit P; Harnchoowong S; Chanasumon N; Sriphojanart T
J Cosmet Dermatol; 2020 Mar; 19(3):714-719. PubMed ID: 31317662
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss.
Ahluwalia GS
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S73-6. PubMed ID: 24326568
[TBL] [Abstract][Full Text] [Related]
13. Application of bimatoprost ophthalmic solution 0.03% for the treatment of eyebrow hypotrichosis: series of ten cases.
Vergilis-Kalner IJ
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945645
[TBL] [Abstract][Full Text] [Related]
14. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
Fagien S
Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
[TBL] [Abstract][Full Text] [Related]
15. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
Fagien S
Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in prostaglandin F2α ethanolamide (prostamide F2α) research and therapeutics.
Woodward DF; Wang JW; Poloso NJ
Pharmacol Rev; 2013; 65(4):1135-47. PubMed ID: 23893067
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
[TBL] [Abstract][Full Text] [Related]
18. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.
Khidhir KG; Woodward DF; Farjo NP; Farjo BK; Tang ES; Wang JW; Picksley SM; Randall VA
FASEB J; 2013 Feb; 27(2):557-67. PubMed ID: 23104985
[TBL] [Abstract][Full Text] [Related]
19. From Eye Care to Hair Growth: Bimatoprost.
Zeppieri M; Gagliano C; Spadea L; Salati C; Chukwuyem EC; Enaholo ES; D'Esposito F; Musa M
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794131
[TBL] [Abstract][Full Text] [Related]
20. Commentary on Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis.
Humphrey S
Dermatol Surg; 2019 Dec; 45(12):1557. PubMed ID: 31135571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
